Compare GODAVARI DRU with HIKAL CHEMIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs HIKAL. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU HIKAL. GODAVARI DRU/
HIKAL.
 
P/E (TTM) x 8.8 33.6 26.2% View Chart
P/BV x 1.8 6.7 26.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 GODAVARI DRU   HIKAL.
EQUITY SHARE DATA
    GODAVARI DRU
Mar-21
HIKAL.
Mar-21
GODAVARI DRU/
HIKAL.
5-Yr Chart
Click to enlarge
High Rs60204 29.3%   
Low Rs1067 14.3%   
Sales per share (Unadj.) Rs162.9139.5 116.8%  
Earnings per share (Unadj.) Rs5.510.8 50.8%  
Cash flow per share (Unadj.) Rs7.117.7 40.1%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs32.475.7 42.8%  
Shares outstanding (eoy) m7.53123.30 6.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.21.0 21.9%   
Avg P/E ratio x6.312.6 50.4%  
P/CF ratio (eoy) x4.97.7 63.8%  
Price / Book Value ratio x1.11.8 59.8%  
Dividend payout %018.5 0.0%   
Avg Mkt Cap Rs m26216,738 1.6%   
No. of employees `000NANA-   
Total wages/salary Rs m391,643 2.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,22717,204 7.1%  
Other income Rs m450 8.2%   
Total revenues Rs m1,23117,254 7.1%   
Gross profit Rs m983,229 3.0%  
Depreciation Rs m12852 1.4%   
Interest Rs m33362 9.2%   
Profit before tax Rs m572,064 2.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m16733 2.2%   
Profit after tax Rs m411,331 3.1%  
Gross profit margin %8.018.8 42.7%  
Effective tax rate %27.735.5 77.9%   
Net profit margin %3.47.7 43.5%  
BALANCE SHEET DATA
Current assets Rs m6769,251 7.3%   
Current liabilities Rs m5057,033 7.2%   
Net working cap to sales %13.912.9 108.1%  
Current ratio x1.31.3 101.8%  
Inventory Days Days126 3.8%  
Debtors Days Days134,256,177103 130,335,842.3%  
Net fixed assets Rs m23510,906 2.2%   
Share capital Rs m75247 30.5%   
"Free" reserves Rs m1699,087 1.9%   
Net worth Rs m2449,334 2.6%   
Long term debt Rs m1452,629 5.5%   
Total assets Rs m91120,157 4.5%  
Interest coverage x2.76.7 40.6%   
Debt to equity ratio x0.60.3 211.0%  
Sales to assets ratio x1.30.9 157.7%   
Return on assets %8.28.4 97.3%  
Return on equity %16.914.3 118.7%  
Return on capital %23.220.3 114.5%  
Exports to sales %1.068.7 1.5%   
Imports to sales %62.126.9 231.0%   
Exports (fob) Rs m1211,823 0.1%   
Imports (cif) Rs m7614,623 16.5%   
Fx inflow Rs m1211,823 0.1%   
Fx outflow Rs m7614,623 16.5%   
Net fx Rs m-7497,200 -10.4%   
CASH FLOW
From Operations Rs m132,290 0.6%  
From Investments Rs m-13-1,562 0.8%  
From Financial Activity Rs m1-969 -0.1%  
Net Cashflow Rs m2-240 -0.9%  

Share Holding

Indian Promoters % 56.1 68.8 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 7.0 7.2%  
FIIs % 0.0 6.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.9 31.2 140.5%  
Shareholders   5,394 68,233 7.9%  
Pledged promoter(s) holding % 14.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   VIVIMED LABS  SUVEN PHARMACEUTICALS  NATCO PHARMA  ALBERT DAVID  S.S.ORGANICS  



Today's Market

SGX Nifty Up 35 Points; Indicates Positive Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:00 am, it was trading up by 35 points, or 0.1% higher at 17,235 levels.

Related Views on News

HIKAL. 2020-21 Annual Report Analysis (Annual Result Update)

Oct 29, 2021 | Updated on Oct 29, 2021

Here's an analysis of the annual report of HIKAL. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of HIKAL.. Also includes updates on the valuation of HIKAL..

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GODAVARI DRU SHARE PRICE


Dec 3, 2021 (Close)

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GODAVARI DRU 8-QTR ANALYSIS

COMPARE GODAVARI DRU WITH

MARKET STATS